Case Study: Redx Pharma achieves faster drug discovery with Dotmatics' integrated informatics platform

The Dotmatics Enterprise Platform is Licensed by Redx Pharma to Aid Their Quest to Develop New Drug Candidates

Redx Pharma, a rapidly expanding UK drug discovery company, faced growing volumes of complex, diverse chemistry and biology data from its Redox Switch™ platform and needed an intuitive, regulatory‑compliant informatics solution. To address these challenges Redx licensed the Dotmatics enterprise platform to provide a single, scalable system for storing and managing experimental data.

Dotmatics implemented its full suite (including Studies Notebook, Browser and Vortex) as an integrated web‑based solution, enabling faster access to data, secure sharing, custom reporting and chemically aware visualization and analytics. The Dotmatics deployment now supports storage, querying and analysis of around 200 families of compounds and their associated datasets, improving collaboration across research groups and addressing Redx Pharma’s needs as it grows.

Redx Pharma

Neil Murray

Chief Executive Officer